NCT04526106
REFOCUS: a First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with ICC and Other Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT04561453
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT04645160
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers treatment 1 / 2 recruiting NCT05286814
M9241 in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer or Intrahepatic Cholangiocarcinoma treatment 2 recruiting NCT06607276
Adebrelimab Combined With Capecitabine for Adjuvant Therapy in Cholangiocarcinoma With High-risk Recurrence Post-surgery treatment 2 not_yet_recruiting NCT06607302
Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma with IDH1 R132 Mutation After At Least One Prior Systemic Treatment - an Observational Study No drug interventions Not Available Not Available not_yet_recruiting NCT05712356
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors treatment 2 recruiting NCT05876754
An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma treatment 3 recruiting NCT06048133
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) treatment 2 recruiting NCT06358001
EchoTip AcuCore Post-Market Clinical Study No drug interventions Not Available Not Available recruiting NCT06399757
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT06474091
Liquid Biopsy MonitORing of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO) No drug interventions Not Available Not Available enrolling_by_invitation NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT05600803
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions No drug interventions Not Available Not Available recruiting NCT04480190
Neoadjuvant Therapy in Biliary Adenocarcinoma treatment 1 withdrawn NCT02631590
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma treatment 2 completed NCT01868490
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells No drug interventions treatment 1 / 2 unknown_status NCT04415190
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients No drug interventions Not Available Not Available unknown_status NCT02436564
In Vitro Models of Liver and Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT04642664
Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer treatment 2 completed NCT00955721
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer treatment 1 / 2 terminated NCT04871321
Biomarker Discovery in Patients With Advanced Biliary Tract Cancer Not Available Not Available recruiting NCT06302621
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors treatment 1 recruiting NCT05788484
A Study of CDX-585 in Patients With Advanced Malignancies No drug interventions treatment 1 recruiting NCT04764084
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors treatment 1 unknown_status NCT03027284
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer treatment 1 completed NCT03377179
A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma treatment 2 completed NCT00301379
Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients No drug interventions Not Available Not Available terminated NCT03602079
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene No drug interventions treatment 1 / 2 completed NCT03339843
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib treatment 2 completed NCT00168987
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors No drug interventions treatment 4 completed NCT05411133
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients No drug interventions treatment 1 recruiting NCT02232633
A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer treatment 2 completed NCT02482454
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma No drug interventions treatment 2 / 3 active_not_recruiting NCT00779454
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma treatment 2 completed NCT00708877
Liver Transplantation for Cholangiocarcinoma No drug interventions treatment Not Available terminated NCT03872947
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors treatment 1 recruiting NCT06441747
Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP) treatment 2 not_yet_recruiting NCT04385147
Advanced Endoscopy During COVID-19 No drug interventions Not Available Not Available completed NCT05694845
Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT06175845
Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma No drug interventions treatment Not Available not_yet_recruiting NCT01844245
Endobiliary RFA for Unresectable Malignant Biliary Strictures No drug interventions treatment Not Available completed NCT01242605
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer treatment 1 completed NCT05012397
Milademetan in Advanced/Metastatic Solid Tumors treatment 2 terminated NCT06416397
Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy No drug interventions Not Available Not Available not_yet_recruiting NCT03144661
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies No drug interventions treatment 1 terminated NCT03833661
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) treatment 2 completed NCT04856761
A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection Not Available Not Available recruiting NCT01151761
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation treatment 2 terminated NCT05348811
HAIC Combined With Donafenib and Sintilimab for Unresectable ICC treatment 2 recruiting NCT02027311
Etomidate vs. Midazolam for Sedation During ERCP treatment 4 completed NCT04572711
Prospective Evaluation of Biliary Tissue Sampling With ERCP No drug interventions Not Available Not Available enrolling_by_invitation NCT06434493
Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma treatment Not Available not_yet_recruiting NCT02479178
A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck treatment 2 terminated NCT00653978
Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures No drug interventions treatment 3 unknown_status NCT04099888
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer treatment 2 terminated NCT03693807
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma treatment 2 completed NCT04037007
Efficacy of Fistulotomy for Biliary Cannulation No drug interventions treatment Not Available unknown_status NCT02638909
Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies treatment 2 terminated NCT03665285
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors No drug interventions treatment 1 / 2 completed NCT03445585
Biobank for Cholestatic Liver Diseases. No drug interventions Not Available Not Available recruiting NCT01439685
Comparison of Biliary Stenting Alone vs. Stenting With Photodynamic Therapy (PDT) During ERCP No drug interventions Not Available Not Available withdrawn NCT01438385
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders No drug interventions Not Available Not Available unknown_status NCT02773485
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma treatment 3 recruiting NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT03150615
Enteral Nutrition After Pancreaticoduodenectomy No drug interventions prevention Not Available completed NCT04238715
A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion No drug interventions treatment 2 active_not_recruiting NCT05697237
Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma No drug interventions treatment Not Available not_yet_recruiting NCT01247337
Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma treatment 2 completed NCT02232932
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma No drug interventions treatment Not Available unknown_status NCT03111732
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) treatment 2 completed NCT02659852
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT00733200
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? No drug interventions Not Available Not Available completed NCT04742959
Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT02757859
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery No drug interventions treatment Not Available recruiting NCT05948475
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma treatment 3 recruiting NCT04584775
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care No drug interventions supportive_care Not Available withdrawn NCT04565275
A Study of ICP-192 in Patients With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01642875
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy No drug interventions prevention 4 unknown_status NCT02452970
RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy treatment 2 terminated NCT03895970
Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors treatment 2 completed NCT04919642
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma treatment 2 completed NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S No drug interventions treatment 1 completed NCT00660699
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers treatment 2 completed NCT02000999
Diagnosis of Bile Duct Strictures No drug interventions Not Available Not Available completed NCT04301999
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC No drug interventions treatment Not Available completed NCT05007106
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) treatment 2 active_not_recruiting NCT05718349
FGF19 in Obstructive Cholestasis: "Unveil the Signal" No drug interventions Not Available Not Available recruiting NCT05655949
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio treatment 2 recruiting NCT00160836
Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter No drug interventions diagnostic 1 unknown_status NCT01755013
Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma No drug interventions supportive_care 2 / 3 unknown_status NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors treatment 2 active_not_recruiting NCT00973713
Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol treatment 2 unknown_status NCT05678218
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT04989218
Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma (ICC) treatment 1 / 2 terminated NCT06440018
INSPIRE: A Multi-Cancer Early Detection Study No drug interventions Not Available Not Available not_yet_recruiting NCT01525719
Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma treatment 2 unknown_status NCT04727541
Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer treatment 2 terminated NCT05653817
Advanced or Metastatic Cholangiocarcinoma treatment Not Available not_yet_recruiting NCT01595217
MRCP Diagnoses EHCC Better When Combined DWI No drug interventions diagnostic Not Available completed NCT05714124
Liver Embolization Approaches for Tumor Management No drug interventions Not Available Not Available recruiting NCT03951324
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study No drug interventions Not Available Not Available unknown_status NCT00290316
Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver No drug interventions diagnostic 2 unknown_status NCT05641896
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers No drug interventions diagnostic 2 recruiting NCT01213758
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT No drug interventions Not Available Not Available completed NCT03438435
Fluorescence QRH-882260 Peptide Imaging in the Bile Duct No drug interventions diagnostic 1 completed NCT00948935
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma treatment 2 completed NCT05207735
PD-1 Inhibitor Sintilimab Combined With Capecitabine for Adjuvant Treatment After Radical Resection of Cholangiocarcinoma. treatment 2 not_yet_recruiting NCT00869635
S-1 and Photodynamic Therapy in Cholangiocarcinoma No drug interventions treatment 3 completed NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome No drug interventions Not Available Not Available recruiting NCT05028439
RFA Combined With Chemotherapy for Unresectable Cholangiocarcinoma treatment Not Available completed NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT01145248
Comparison of Biliary Forceps Biopsy and Brush Cytology No drug interventions diagnostic Not Available completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT02528526
Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm No drug interventions treatment 1 / 2 unknown_status NCT03734926
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03267966
Margin Status After Pancreaticoduodenectomy for Cancer No drug interventions diagnostic Not Available completed NCT06304766
Open Versus Laparoscopic Ablation of Liver Malignancies No drug interventions treatment Not Available recruiting NCT00604266
Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study No drug interventions Not Available Not Available withdrawn NCT05215665
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma treatment Not Available recruiting NCT03003065
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers treatment 2 completed NCT01739465
Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma No drug interventions treatment 2 / 3 unknown_status NCT03452774
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry No drug interventions Not Available Not Available recruiting NCT03473574
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients treatment 2 completed NCT04308174
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer treatment 2 active_not_recruiting NCT02128282
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma treatment 1 / 2 completed NCT05967182
A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma treatment 2 recruiting NCT03042182
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma No drug interventions treatment 1 / 2 unknown_status NCT02012231
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. treatment 1 terminated NCT05497531
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers No drug interventions diagnostic Not Available recruiting NCT01522573
T-EUS for Gastrointestinal Disorders: A Multicenter Registry No drug interventions Not Available Not Available unknown_status NCT06355427
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma No drug interventions diagnostic 2 / 3 not_yet_recruiting NCT04668976
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma treatment 2 recruiting NCT02073994
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation treatment 1 completed NCT04100694
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor Not Available Not Available available NCT04068194
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies treatment 1 / 2 recruiting NCT04149691
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies No drug interventions treatment 1 recruiting NCT06010862
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT04059562
Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma treatment 2 completed NCT03041662
Surveillance Study for Early Detection of Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC) No drug interventions Not Available Not Available completed NCT06037980
CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence treatment 2 / 3 recruiting NCT02375880
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder treatment 1 completed NCT06369480
Prognostic Factors for Survival in Patients With Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT03414489
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®) Not Available Not Available available NCT04137289
A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer No drug interventions treatment 1 completed NCT03774589
Bilioenteric Anastomosis by Magnetic Compressive Technique No drug interventions treatment Not Available unknown_status NCT05321992
Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand No drug interventions prevention Not Available not_yet_recruiting NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT05872867
Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) treatment 1 recruiting NCT04306367
Study of Pembrolizumab and Olaparib in Bile Duct Cancer treatment 2 active_not_recruiting NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) treatment 2 active_not_recruiting NCT04233567
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations treatment 2 active_not_recruiting NCT01501604
BKM120 in Cancers With PIK3CA Activating Mutations treatment 2 withdrawn NCT04504604
TCF-001 TRACK (Target Rare Cancer Knowledge) Study No drug interventions diagnostic Not Available recruiting NCT05194072
A Study of SGN-B7H4V in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT01043172
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection treatment 2 completed NCT03102268
ncRNAs in Exosomes of Cholangiocarcinoma No drug interventions Not Available Not Available unknown_status NCT03211169
Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures No drug interventions diagnostic Not Available terminated NCT01859169
Safety and Efficiency of Photodynamic Therapy for Blie Duct Carcinoma No drug interventions Not Available Not Available suspended NCT06340646
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) No drug interventions health_services_research Not Available recruiting NCT04568512
DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture No drug interventions diagnostic Not Available completed NCT02649712
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction No drug interventions treatment Not Available completed NCT05187312
Registry for Advanced Endoscopy No drug interventions Not Available Not Available recruiting NCT04383210
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors treatment 2 active_not_recruiting NCT02990481
A Study of TRK-950 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT02548195
Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma prevention 3 unknown_status NCT02784795
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors treatment 1 completed NCT02428855
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma treatment 2 completed NCT00465023
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases No drug interventions treatment Not Available completed NCT06363123
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis No drug interventions Not Available Not Available recruiting NCT02592538
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma No drug interventions treatment Not Available completed NCT06260943
Targeted Navigation in Hepatocellular Carcinoma (HCC) No drug interventions supportive_care Not Available recruiting NCT05506943
A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) treatment 2 / 3 active_not_recruiting NCT05451043
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) treatment 2 recruiting NCT04440943
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies No drug interventions treatment 1 completed NCT03943043
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer treatment 1 / 2 unknown_status NCT01920503
International Registry on Cholangiocarcinoma Treatment Not Available Not Available unknown_status NCT02170090
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer treatment 3 active_not_recruiting NCT00630890
Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) No drug interventions treatment 1 terminated NCT06341764
Neo-adjuvant Chemo and Immunotherapy in The Pre-operAtive Treatment of Locally Advanced cholangIOcarciNoma treatment 2 recruiting NCT02762721
Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples No drug interventions Not Available Not Available completed NCT00797121
Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma No drug interventions prevention 4 unknown_status NCT01673802
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma No drug interventions treatment 0 completed NCT05346484
A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors treatment 1 recruiting NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT04717687
Pilot Study on the Evaluation of Irreversible Electroporation Technique in Infiltrating Perihilar Cholangiocarcinoma No drug interventions treatment Not Available withdrawn NCT00713687
Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma treatment 2 withdrawn NCT04676633
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy treatment 1 completed NCT04566133
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC). treatment 2 terminated NCT01438554
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma other 1 completed NCT02821754
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) treatment 2 completed NCT03769753
Trial of IRE in Cholangiocarcinoma No drug interventions treatment 2 completed NCT00350753
Avastin and Tarceva for Upper Gastrointestinal Cancers treatment 2 completed NCT01912053
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma No drug interventions treatment 2 completed NCT05253053
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors treatment 1 / 2 recruiting NCT02379377
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant diagnostic 1 recruiting NCT03207347
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) treatment 2 completed NCT00230347
Evaluation of Stereotactic Radiosurgery For Liver Malignancies No drug interventions treatment 1 completed NCT01439698
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry No drug interventions Not Available Not Available unknown_status NCT06490198
Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin treatment 1 not_yet_recruiting NCT05519605
Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD No drug interventions Not Available Not Available active_not_recruiting NCT03801083
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers No drug interventions treatment 2 recruiting NCT00350961
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma treatment 1 / 2 completed NCT04076761
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma treatment 2 terminated NCT05580328
An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma treatment Not Available not_yet_recruiting NCT02167711
Treatment for Bile Duct Cancer in the Liver treatment 2 completed NCT02730611
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma No drug interventions Not Available Not Available completed NCT05432193
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) treatment 1 active_not_recruiting NCT03999593
Long-term Morbidity After Surgery for Perihilar Cholangiocarcinoma No drug interventions Not Available Not Available completed NCT02106871
Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer supportive_care 1 withdrawn NCT05518071
FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 No drug interventions treatment 2 completed NCT02052778
A Study of TAS-120 in Patients With Advanced Solid Tumors treatment 1 / 2 completed NCT04316078
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies No drug interventions health_services_research Not Available completed NCT03486678
SHR-1210 in Combination With GEMOX in Patients With Advanced BTC treatment 2 completed NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT03140007
Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic . No drug interventions other Not Available unknown_status NCT03178409
Combined HCC-MFCCC No drug interventions Not Available Not Available completed NCT06290856
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy No drug interventions Not Available Not Available recruiting NCT02585856
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma No drug interventions treatment Not Available completed NCT04644315
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors treatment 2 terminated NCT03801915
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers No drug interventions treatment 2 completed NCT04913337
Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT01135732
Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy No drug interventions Not Available Not Available completed NCT03172832
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors No drug interventions treatment Not Available terminated NCT03991832
Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors treatment 2 recruiting NCT04445532
Hepatobiliary Tumors Tissue Samples Acquisition No drug interventions Not Available Not Available recruiting NCT03563352
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer No drug interventions Not Available Not Available withdrawn NCT01007552
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts treatment 2 completed NCT05921552
Senior Adult Hepatobiliary Prehab Study No drug interventions supportive_care Not Available recruiting NCT06541652
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers No drug interventions Not Available Not Available recruiting NCT05184400
Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer No drug interventions Not Available Not Available recruiting NCT01434459
Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin treatment 1 terminated NCT05292859
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs No drug interventions Not Available Not Available active_not_recruiting NCT01303159
Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer No drug interventions treatment Not Available terminated NCT02917759
Liver and Biliary Tumor Tissue Registry No drug interventions Not Available Not Available recruiting NCT02174575
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery prevention 4 withdrawn NCT05596370
Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer No drug interventions Not Available Not Available recruiting NCT03278106
TAS-102 in Treating Advanced Biliary Tract Cancers treatment 2 completed NCT05464706
Study on the Quality of Life (QoL) After Liver Surgery No drug interventions supportive_care Not Available completed NCT06126406
Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors No drug interventions treatment 1 recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT00955149
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) prevention 1 completed NCT01206049
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations treatment 2 completed NCT04656249
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer treatment 2 completed NCT01875549
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent No drug interventions treatment Not Available withdrawn NCT01290536
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases No drug interventions treatment 2 completed NCT04866836
A Study of Tislelizumab Combined With Radiotherapy as the Second-line Treatment of Advanced Biliary Malignant Tumors treatment 2 unknown_status NCT03166436
RFA for Malignant Biliary Obstruction No drug interventions treatment Not Available unknown_status NCT01926236
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers treatment 3 completed NCT04484636
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) No drug interventions other Not Available recruiting NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT03852836
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images No drug interventions diagnostic Not Available terminated NCT00907413
Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma No drug interventions treatment 3 terminated NCT06370013
Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors Not Available Not Available available NCT00320918
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib No drug interventions Not Available Not Available terminated NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT04648319
A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma treatment 2 terminated NCT02582541
Endoscopic Biliary RFA of Malignant Bile Duct Obstruction No drug interventions treatment Not Available unknown_status NCT04145141
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer No drug interventions Not Available Not Available recruiting NCT02496741
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors treatment 1 / 2 completed NCT02520141
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery treatment 2 completed NCT04853017
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT03603834
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma treatment 2 unknown_status NCT02181634
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma treatment 2 completed NCT01442324
Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma No drug interventions treatment Not Available unknown_status NCT01855724
Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer treatment 2 terminated NCT06258824
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers No drug interventions Not Available Not Available completed NCT06369896
Digital Single-operator Cholangioscopy and Intraductal Ultrasound for Nonicteric Biliary Strictures No drug interventions Not Available Not Available not_yet_recruiting NCT04753996
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients No drug interventions Not Available Not Available recruiting NCT02609958
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy treatment 2 completed NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available unknown_status NCT01900158
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas treatment 1 completed NCT00540735
Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas No drug interventions treatment 3 terminated NCT03779035
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection treatment 3 unknown_status NCT05194735
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors treatment 1 / 2 active_not_recruiting NCT05721963
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients No drug interventions Not Available Not Available recruiting NCT05724563
Domvanalimab and Zimberelimab in Advanced Liver Cancers treatment 2 recruiting NCT04340986
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT05179486
Molecular Epidemiology of Biliary Tree Cancers No drug interventions Not Available Not Available recruiting NCT04521686
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations treatment 1 active_not_recruiting NCT04683939
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors treatment 1 / 2 terminated NCT00975039
Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma No drug interventions treatment 2 terminated NCT06438822
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma treatment 2 not_yet_recruiting NCT01963325
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma treatment 2 completed NCT01915225
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer No drug interventions Not Available Not Available recruiting NCT04637048
Observational Study on Patients With Hepatobiliary Tumors No drug interventions Not Available Not Available unknown_status NCT02393248
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) treatment 1 / 2 terminated NCT03792048
Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure No drug interventions treatment Not Available unknown_status NCT01253148
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma No drug interventions treatment Not Available completed NCT06381648
Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC) No drug interventions Not Available Not Available recruiting NCT04243057
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study No drug interventions Not Available Not Available unknown_status NCT02607826
Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors No drug interventions supportive_care Not Available unknown_status NCT03924466
Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients No drug interventions diagnostic 2 recruiting NCT02351765
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers treatment 1 completed NCT06570174
Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients No drug interventions supportive_care Not Available completed NCT01392274
pCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture No drug interventions Not Available Not Available completed NCT01721174
Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures No drug interventions treatment Not Available terminated NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 recruiting NCT04421820
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT04633382
ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY No drug interventions treatment Not Available unknown_status NCT03499782
Precise Treatment System of Biliary Malignancies Based on Special Disease Database No drug interventions Not Available Not Available unknown_status NCT02872831
Beacon BNX™ Endoscopic Ultrasound (EUS)-Needle vs SharkCore™ Needle No drug interventions treatment Not Available terminated NCT02081131
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT) No drug interventions treatment Not Available completed NCT04459273
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers basic_science 1 recruiting NCT03250273
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma treatment 2 completed NCT04946773
Deep Liver Phenotyping and Immunology Study No drug interventions Not Available Not Available recruiting NCT03644173
Personal Resilience Empowerment Program Study No drug interventions supportive_care Not Available completed NCT05510427
Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification treatment 1 withdrawn NCT03079427
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma treatment 2 completed NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT02468076
Radiofrequency Ablation for Biliopancreatic Malignancy No drug interventions treatment 2 completed NCT02924376
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202) treatment 2 completed NCT05634694
Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients No drug interventions Not Available Not Available recruiting NCT02665494
Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors No drug interventions Not Available Not Available unknown_status NCT04066491
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC treatment 2 / 3 terminated NCT03338062
A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy No drug interventions diagnostic Not Available completed NCT04256980
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement treatment 2 completed NCT00426829
Proton Therapy and Bevacizumab for Primary Liver Tumors treatment 1 terminated NCT05993429
Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT02374489
A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma treatment 2 terminated NCT06048289
Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy No drug interventions Not Available Not Available recruiting NCT01267344
A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC treatment 2 completed NCT00660140
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer treatment 2 completed NCT04510740
Liver Cancer Registry Platform No drug interventions Not Available Not Available recruiting NCT04077372
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers No drug interventions supportive_care Not Available terminated NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors diagnostic 2 recruiting NCT03219268
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms treatment 1 completed NCT03613168
Trastuzumab in HER2-positive Biliary Tract Cancer treatment 2 completed NCT03637569
The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer No drug interventions Not Available Not Available recruiting NCT01525069
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma treatment 1 terminated NCT01673269
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD No drug interventions diagnostic Not Available completed NCT04895046
Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma treatment 2 withdrawn NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function No drug interventions treatment 1 active_not_recruiting NCT03820310
Clinical Trial of Autologous Tcm Immunotherapy in ICC No drug interventions treatment 2 recruiting NCT04304781
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer No drug interventions screening 1 terminated NCT04801095
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06199895
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer treatment 2 recruiting NCT02162914
Regorafenib Versus Placebo to Treat Cholangiocarcinoma treatment 2 unknown_status NCT05874414
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutation Cholangiocarcinoma treatment 1 / 2 recruiting NCT02456714
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma No drug interventions treatment 2 completed NCT06342414
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer No drug interventions Not Available Not Available recruiting NCT01773655
Clinical and Histopathologic Characteristics of BAP1 Mutations No drug interventions Not Available Not Available completed NCT03329950
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies treatment 1 completed NCT05489250
The PLATON Network No drug interventions Not Available Not Available recruiting NCT05957250
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer No drug interventions diagnostic Not Available recruiting NCT06530823
Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma treatment 2 not_yet_recruiting NCT00041808
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver treatment 1 / 2 completed NCT04430738
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers treatment 1 / 2 active_not_recruiting NCT02683538
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies No drug interventions treatment 2 completed NCT05124743
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors No drug interventions Not Available Not Available suspended NCT00414843
Storage of Bile From Routine Procedures to Study Risk Factors No drug interventions Not Available Not Available terminated NCT01320254
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) treatment 2 completed